Brain tumour treatment in Turkey

Brain tumours are divided first into those that start in the brain and those that have spread there from elsewhere, and the second group is treated as the original cancer with brain involvement rather than as a brain tumour. Among those that start in the brain, behaviour ranges from slow-growing lesions that may never need anything done to aggressive ones that need treatment immediately.

This is why a person with a scan and a frightening word has no way to compare offers yet. The right question is not who will operate and for how much, it is what exactly this is. Everything after that, including whether an operation is the right first move at all, follows from the answer.

• Found by accident, no symptoms

  Some tumours are found on a scan done for headaches or an injury. A number of these are watched with repeat imaging rather than treated, and being told to wait is a real medical decision.

• Benign but causing pressure

  A tumour can be non-cancerous and still need removing because of where it sits and what it presses on. Benign is about the cells, not about how serious the situation is.

• Aggressive and time-critical

  Some diagnoses need treatment started quickly, and this is precisely where travel plans cost more than they save.

• Spread from a cancer elsewhere

  Treated as that cancer with brain involvement. The plan comes from the primary tumour's team, and focused radiotherapy is often part of it.

For the wider cancer service see oncology in Turkey, and for the radiotherapy platforms used in some brain cases see tomotherapy and TrueBeam.

Treatment is a sequence, not an event. Surgery or biopsy, then pathology and molecular testing that take time to come back, then in many cases radiotherapy given daily over several weeks, then chemotherapy in cycles over months, then surveillance imaging at intervals for years. Each step depends on the results of the one before, and the people making those decisions need the whole record.

A short trip can deliver an operation. It cannot deliver that sequence, and the parts it cannot deliver are the parts that determine how the years afterwards go. If you are considering treatment abroad, the questions that matter are who holds the plan, where the radiotherapy and chemotherapy happen, and who reads the scans at six months and at two years.

• How much is removed matters. For several tumour types the amount safely removed affects what follows. That is why techniques such as neuronavigation, fluorescence guidance and intraoperative monitoring exist.
• Awake surgery has a specific purpose. When a tumour sits near speech or movement areas, operating with the person awake lets the team map function and stop before crossing it.
• Not every tumour should be resected. Position, type and the person's condition can all make biopsy or treatment without surgery the better plan.
• Surgery is rarely the whole treatment. For most malignant tumours it is the first step in a sequence, and judging a clinic only on its operation misses most of the care.
• Neurological deficits are the specific risk. Weakness, speech difficulty, visual field loss and seizures are the possibilities that make this different from other surgery, and they depend on where the tumour is.
• Swelling, bleeding, infection and fluid build-up. The general risks of brain surgery, managed by teams that do this often and have neurointensive care available.

• Send the imaging itself, not the report. And ask whether their neuroradiologist has reviewed the actual images before any opinion is given.
• Ask which hospital and what neurointensive care is available. Brain surgery is not a clinic procedure, and the answer should name a department, not a brand.
• Ask who operates and in what specialty. Neurosurgery, and within it the subspecialty interest, should be verifiable before you travel.
• Ask where radiotherapy and chemotherapy would happen. And whether they are included, because they are the longest and most often excluded part.
• Ask what you take home. Operative note, pathology report, molecular results, imaging and the treatment plan, in a form your own team can use.
• Agree the follow-up before you fly. Who reviews the scans, at what intervals, and how your doctors at home reach them.

• World Health Organization, classification of tumours of the central nervous system.
• National Institute for Health and Care Excellence, guideline on brain tumours and brain metastases.
• European Association of Neuro-Oncology, guidelines on the diagnosis and treatment of gliomas.
• Cancer Research UK, patient information on brain tumour types and treatment.
• Turkish Ministry of Health, register of facilities licensed for health tourism.